Eli Lilly Market Cap 2006-2019 | LLY

Eli Lilly market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Eli Lilly market cap as of April 03, 2020 is $133.66B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $133.660B $22.320B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $353.719B 15.46
Roche Holding AG (RHHBY) Switzerland $281.610B 0.00
Merck (MRK) United States $193.391B 14.69
Novartis AG (NVS) Switzerland $191.686B 15.96
Pfizer (PFE) United States $186.623B 11.40
Novo Nordisk (NVO) Denmark $141.701B 24.33
Bristol-Myers Squibb (BMY) United States $125.360B 11.89
AstraZeneca (AZN) United Kingdom $115.367B 24.84
Sanofi (SNY) France $112.261B 13.34
AbbVie (ABBV) United States $108.343B 8.21
GlaxoSmithKline (GSK) United Kingdom $92.675B 11.75
Bayer (BAYRY) Germany $53.491B 7.71
H Lundbeck (HLUYY) Denmark $5.974B 10.38
Innoviva (INVA) United States $1.170B 8.08